Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Nickel Sensitivity

NCT: NCT04058743 · TERMINATED

NCT IDNCT04058743
StatusTERMINATED
Start Date2019-09-27
Completion2024-12-21

Brief Summary

The purpose of this study is to compare clinical outcomes of patients with self reported nickel sensitivity undergoing primary total knee arthroplasty (TKA) with conventional, standard-of-care vs nickel-free implants. The hypothesis is that patients with a self-reported nickel sensitivity will have similar patient reported outcome scores compared to those patients without reported nickel sensitivity. Therefor the anticipation is for there to be no differences in other clinical outcome measures or functional outcome scores between the two cohorts.

Frequently Asked Questions

What is Nickel Sensitivity?

Nickel Sensitivity is a clinical trial registered under NCT04058743. Current status: TERMINATED.

What is the status of NCT04058743?

The current status of NCT04058743 (Nickel Sensitivity) is: TERMINATED.

When did Nickel Sensitivity start?

Nickel Sensitivity started on 2019-09-27.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.